Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Edoxudine | hsa00030 | Pentose phosphate pathway | 8.97E-03 | 1 | P11413 | G6PD | More | | Edoxudine | hsa00240 | Pyrimidine metabolism | 8.44E-04 | 4 | P31350, P21589, P32320, P04183 | RRM2, NT5E, CDA, TK1 | More | | Edoxudine | hsa00471 | D-Glutamine and D-glutamate metabolism | 2.41E-02 | 1 | P49448 | GLUD2 | More | | Edoxudine | hsa00480 | Glutathione metabolism | 1.35E-02 | 1 | P11413 | G6PD | More | | Edoxudine | hsa00983 | Drug metabolism - other enzymes | 3.83E-04 | 4 | P04183, P32320, P31350, P05164 | TK1, CDA, RRM2, MPO | More | | Edoxudine | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.77E-02 | 1 | O00767 | SCD | More | | Edoxudine | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | | Edoxudine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.80E-02 | 2 | P17252, Q9GZP0 | PRKCA, PDGFD | More | | Edoxudine | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Edoxudine | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Edoxudine | hsa04010 | MAPK signaling pathway | 5.69E-03 | 4 | P17252, O95267, P09603, Q9GZP0 | PRKCA, RASGRP1, CSF1, PDGFD | More | | Edoxudine | hsa04014 | Ras signaling pathway | 2.60E-03 | 4 | P09603, Q9GZP0, P17252, O95267 | CSF1, PDGFD, PRKCA, RASGRP1 | More | | Edoxudine | hsa04015 | Rap1 signaling pathway | 1.84E-04 | 5 | P09603, Q9GZP0, P25116, P08514, P17252 | CSF1, PDGFD, F2R, ITGA2B, PRKCA | More | | Edoxudine | hsa04020 | Calcium signaling pathway | 1.21E-02 | 3 | P17252, P25116, Q9GZP0 | PRKCA, F2R, PDGFD | More | | Edoxudine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.28E-02 | 7 | P51684, P09341, P25024, P25025, P47992, Q9UBD3, P01375 | CCR6, CXCL1, CXCR1, CXCR2, XCL1, XCL2, TNF | More | | Edoxudine | hsa04064 | NF-kappa B signaling pathway | 2.37E-04 | 11 | P10415, P51617, O00463, P01375, Q04759, Q9UDY8, Q13077, Q16548, Q13315, P24522, P09341 | BCL2, IRAK1, TRAF5, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, ATM, GADD45A, CXCL1 | More | | Edoxudine | hsa04071 | Sphingolipid signaling pathway | 9.29E-03 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Edoxudine | hsa04072 | Phospholipase D signaling pathway | 7.75E-03 | 3 | P25116, P17252, Q9GZP0 | F2R, PRKCA, PDGFD | More | | Edoxudine | hsa04115 | p53 signaling pathway | 3.35E-03 | 5 | P24522, Q13315, P31350, O95067, P10415 | GADD45A, ATM, RRM2, CCNB2, BCL2 | More | | Edoxudine | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Edoxudine | hsa04145 | Phagosome | 1.73E-03 | 6 | Q15080, P68371, P05164, P78380, P35443, P13765 | NCF4, TUBB2C, MPO, OLR1, THBS4, HLA-DOB | More | | Edoxudine | hsa04151 | PI3K-Akt signaling pathway | 4.16E-03 | 5 | P25116, P09603, Q9GZP0, P08514, P17252 | F2R, CSF1, PDGFD, ITGA2B, PRKCA | More | | Edoxudine | hsa04217 | Necroptosis | 4.42E-04 | 6 | P07900, P15104, P05141, P01584, P0C0S5, Q13557 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D | More | | Edoxudine | hsa04350 | TGF-beta signaling pathway | 3.68E-02 | 2 | Q14766, Q15583 | LTBP1, TGIF1 | More | | Edoxudine | hsa04510 | Focal adhesion | 2.93E-02 | 3 | P08514, P17252, Q9GZP0 | ITGA2B, PRKCA, PDGFD | More | | Edoxudine | hsa04540 | Gap junction | 2.22E-02 | 2 | P17252, Q9GZP0 | PRKCA, PDGFD | More | | Edoxudine | hsa04610 | Complement and coagulation cascades | 2.67E-02 | 2 | P25116, Q9Y279 | F2R, VSIG4 | More | | Edoxudine | hsa04611 | Platelet activation | 4.53E-03 | 3 | P25116, O95267, P08514 | F2R, RASGRP1, ITGA2B | More | | Edoxudine | hsa04612 | Antigen processing and presentation | 4.72E-02 | 4 | P13765, P48382, P26715, P26717 | HLA-DOB, RFX5, KLRC1, KLRC2 | More | | Edoxudine | hsa04613 | Neutrophil extracellular trap formation | 1.02E-02 | 14 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Edoxudine | hsa04621 | NOD-like receptor signaling pathway | 4.83E-02 | 10 | Q16539, Q14643, Q9H1Y0, P43490, O00463, P10415, P01375, P09341, P49913, P12838 | MAPK14, ITPR1, ATG5, PBEF1, TRAF5, BCL2, TNF, CXCL1, CAMP, DEFA4 | More | | Edoxudine | hsa04640 | Hematopoietic cell lineage | 1.75E-02 | 3 | P08514, P11836, P09603 | ITGA2B, MS4A1, CSF1 | More | | Edoxudine | hsa04650 | Natural killer cell mediated cytotoxicity | 1.56E-02 | 3 | P17252, P26717, P26715 | PRKCA, KLRC2, KLRC1 | More | | Edoxudine | hsa04657 | IL-17 signaling pathway | 4.87E-02 | 2 | P07900, P01584 | HSP90AA1, IL1B | More | | Edoxudine | hsa04658 | Th1 and Th2 cell differentiation | 8.47E-03 | 8 | Q04759, P20963, P09693, Q16539, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, STAT4, GATA3, TBX21, HLA-DOB | More | | Edoxudine | hsa04660 | T cell receptor signaling pathway | 2.57E-03 | 11 | P01375, Q9UDY8, Q04759, P10747, O95267, Q08881, P20963, P09693, P01732, Q13191, Q16539 | TNF, MALT1, PRKCQ, CD28, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, MAPK14 | More | | Edoxudine | hsa04810 | Regulation of actin cytoskeleton | 1.21E-02 | 3 | P08514, Q9GZP0, P25116 | ITGA2B, PDGFD, F2R | More | | Edoxudine | hsa04932 | Non-alcoholic fatty liver disease | 9.70E-03 | 4 | P18848, P01584, P13073, O15239 | ATF4, IL1B, COX4I1, NDUFA1 | More | | Edoxudine | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | | Edoxudine | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Edoxudine | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | | Edoxudine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.80E-02 | 6 | O15239, P13073, P18848, P05141, P01584, Q13557 | NDUFA1, COX4I1, ATF4, SLC25A5, IL1B, CAMK2D | More | | Edoxudine | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Edoxudine | hsa05146 | Amoebiasis | 3.11E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Edoxudine | hsa05150 | Staphylococcus aureus infection | 2.53E-02 | 6 | P21730, P21462, O75015, P13765, P12838, P49913 | C5AR1, FPR1, FCGR3B, HLA-DOB, DEFA4, CAMP | More | | Edoxudine | hsa05152 | Tuberculosis | 1.16E-03 | 10 | O75015, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, Q16539, P51617 | FCGR3B, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, MAPK14, IRAK1 | More | | Edoxudine | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Edoxudine | hsa05170 | Human immunodeficiency virus 1 infection | 4.82E-02 | 11 | P01375, O00463, Q14643, Q16539, O60603, Q13315, P09693, P20963, P10415, Q93034, Q9Y6Q5 | TNF, TRAF5, ITPR1, MAPK14, TLR2, ATM, CD3G, CD247, BCL2, CUL5, AP1M2 | More | | Edoxudine | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Edoxudine | hsa05202 | Transcriptional misregulation in cancer | 1.01E-03 | 15 | Q15532, Q13315, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Edoxudine | hsa05221 | Acute myeloid leukemia | 3.29E-02 | 3 | P14923, Q15744, P05164 | JUP, CEBPE, MPO | More | | Edoxudine | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | | Edoxudine | hsa05231 | Choline metabolism in cancer | 2.22E-02 | 2 | Q9GZP0, P17252 | PDGFD, PRKCA | More | | Edoxudine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.11E-02 | 7 | O95267, P20963, P09693, O60603, P10747, Q04759, Q16539 | RASGRP1, CD247, CD3G, TLR2, CD28, PRKCQ, MAPK14 | More | | Edoxudine | hsa05310 | Asthma | 1.68E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Edoxudine | hsa05321 | Inflammatory bowel disease | 2.47E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Edoxudine | hsa05322 | Systemic lupus erythematosus | 4.61E-02 | 8 | O75015, P08246, P08311, P01375, P10747, P13765, Q6FI13, P05455 | FCGR3B, ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, SSB | More | | Edoxudine | hsa05323 | Rheumatoid arthritis | 2.84E-02 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | | Edoxudine | hsa05332 | Graft-versus-host disease | 3.93E-03 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Edoxudine | hsa05415 | Diabetic cardiomyopathy | 7.11E-03 | 5 | P05141, O15239, P13073, Q13557, P11413 | SLC25A5, NDUFA1, COX4I1, CAMK2D, G6PD | More | | |